The IUPHAR Guide to IMMUNOPHARMACOLOGY ligand list
GtoImmuPdb ligands only: Low molecular weight, non-polymeric compounds produced via either total synthesis or semi-synthetic processes.
A B C D E F G H I J K L M N O P Q R S T U V W Y Z
| Ligand name | ID | Synonyms | ||||||
| A | Back to top | |||||||
| 852A |
|
9025 | ||||||
| A286982 |
|
6592 | A 286982, A-286982 | |||||
| A438079 |
|
4118 | A 438079, A-438079 | |||||
| abediterol |
|
9326 | LAS-100977 | |||||
| ABT-737 |
|
|
8320 | ABT 737, ABT737, compound 2 [PMID 17256834] | ||||
| AC430 |
|
9177 | AC-430 | |||||
| acalabrutinib |
|
|
8912 | ACP-196, Calquence®, Example 6 [US20140155385 A1] | ||||
| ACT-389949 |
|
9511 | ||||||
| acumapimod |
|
9203 | BCT 197, BCT-197, BCT197, compound A [WO2013139809] | |||||
| adavivint |
|
9620 | SM0-4690, SM04690 | |||||
| ADU-S100 |
|
10192 | dithio-(Rp,Rp)-[cyclic[A(2',5')pA(3',5')p]], MIW815, ML RR-S2 CDA, S100 | |||||
| agatolimod |
|
9843 | CpG 7909, CpG7909, PF 3512676, PF-3512676, ProMune, VaxImmune | |||||
| AH10-7 |
|
9899 | ||||||
| AH6809 |
|
1896 | AH 6809, AH-6809 | |||||
| alcaftadine |
|
|
7587 | Lastacaft®, R-89674 | ||||
| alimemazine |
|
|
7237 | Nedeltran®, trimeprazine | ||||
| alpelisib |
|
|
7955 | BYL 719, BYL-719, NVP-BYL719 | ||||
| 3 alpha-aminocholestane |
|
9564 | 3AC, 3 α-aminocholestane | |||||
| alvelestat |
|
6476 | AZD 9668, AZD-9668, AZD9668, KB-105160 | |||||
| AM-461 |
|
10170 | AM461, Compound 1 [WO2011085033] | |||||
| amcinonide |
|
|
7060 | CL-34699, Cyclocort® | ||||
| amelubant |
|
8463 | BIIL 284, BIIL-284 | |||||
| AMG319 |
|
|
8917 | AMG 319, AMG-319 | ||||
| aminopyridine 2 |
|
10051 | ||||||
| amiselimod |
|
9319 | Example 1 [US20090137530], MT-1303, MT1303 | |||||
| amiselimod phosphate |
|
9491 | amiselimod-P | |||||
| amlexanox |
|
|
|
7113 | AA-673, Amlexanox®, Aphthasol®, CHX-3673 | |||
| ancriviroc |
|
804 | SCH 351125, SCH-351125, SCH-C | |||||
| andrographolide |
|
9675 | ||||||
| apafant |
|
1860 | WEB 2086 BS, WEB-2086 | |||||
| apilimod |
|
9859 | STA 5326, STA-5326, STA5326 | |||||
| apratastat |
|
6482 | compound 5h [PMID: 16426848], TMI-05, TMI005 | |||||
| apremilast |
|
|
7372 | CC-10004, Otezla® | ||||
| arformoterol |
|
|
|
7479 | Brovana®, YM-08316 | |||
| ARN19702 |
|
|
10120 | ARN-19702, compound 8 [PMID: 27404798] | ||||
| ARN726 |
|
9178 | ARN-726, compound 6 [PMID: 25874594] | |||||
| (R)-ARN2508 |
|
9000 | compound (-)-10r [PMID: 26774927], example 19 [WO2014023643] | |||||
| (S)-ARN2508 |
|
|
8999 | compound (+)-10r [PMID: 26774927], example 20 [WO2014023643] | ||||
| ARRY-382 |
|
9108 | ARRY 382, ARRY382 | |||||
| ARRY-502 |
|
10179 | ARRY502, example 237, enantiomer 1 [WO2009158426A1] | |||||
| AS101 |
|
437 | ammonium tri-chloro(dioxoethylene-O,O'-)tellurate, AS 101, AS-101 | |||||
| asimadoline |
|
9279 | EMD 61 753, EMD 61753, EMD-61753 | |||||
| asivatrep |
|
9621 | Example 230 [US7858621], PAC-14028 | |||||
| ASN002 |
|
10000 | example 189 [WO2013028818A1], gusacitinib (proposed INN) | |||||
| ASP4058 |
|
9569 | ASP-4058 | |||||
| aspirin |
|
|
|
4139 | Acetophen®, acetylsalicylic acid, Aspirin® | |||
| AT38 |
|
9020 | [3-(aminocarbonyl)furoxan-4-yl]methyl salicylate | |||||
| ATB-346 |
|
9534 | ATB 346 | |||||
| atracurium |
|
|
9537 | atracurium besilate, atracurium dibesylate, BW 33A, Tracrium® | ||||
| auranofin |
|
|
6306 | Ridaura®, SK&F-39162, SK-39162 | ||||
| avacopan |
|
|
9450 | CCX-168, CCX168 | ||||
| AVE 0991 |
|
5579 | AVE-0991, AVE0991 | |||||
| AZ13102909 |
|
9577 | AZ909 | |||||
| AZ2 |
|
|
10233 | |||||
| AZ3451 |
|
|
9560 | |||||
| AZ7188 |
|
9586 | ||||||
| AZ8838 |
|
|
9585 | |||||
| azacitidine |
|
|
|
6796 | 5-AZAC, 5-azacytidine, ladakamycin, U-18496, Vidaza® | |||
| azatadine |
|
|
7119 | Optimine®, SCH-10649 | ||||
| azathioprine |
|
|
7120 | Azasan®, BW-57-322, Imuran® | ||||
| AZD1236 |
|
7844 | AZD 1236, AZD-1236 | |||||
| AZD1678 |
|
9679 | AZD-1678, compound 49 [PMID: 28947948] | |||||
| AZD1981 |
|
7680 | AZD 1981, AZD-1981 | |||||
| AZD2098 |
|
9678 | AZD-2098, compound 47 [PMID: 28947948] | |||||
| AZD2423 |
|
7825 | AZD 2423, AZD-2423 | |||||
| AZD4635 |
|
|
9236 | AZD-4635, compound 4g [PMID: 22220592], Example XCII [US20160175314], HTL-1071, HTL1071 | ||||
| AZD5069 |
|
8948 | ||||||
| AZD5672 |
|
7686 | AZD 5672, AZD-5672 | |||||
| AZD6605 |
|
7823 | AZ 11920155, AZ-11920155, AZ11920155, AZD 6605, AZD-6605 | |||||
| AZD6703 |
|
|
7687 | AZ 12012199, AZ-12012199, AZ12012199, AZD 6703, AZD-6703 | ||||
| AZD7594 |
|
9325 | AZ13189620, compound 15m [PMID: 28937774] | |||||
| AZD7986 |
|
9412 | compound 30 | |||||
| AZD8848 |
|
9256 | DSP-3025 | |||||
| AZD9056 |
|
7826 | AZD 9056, AZD-9056 | |||||
| AZD9567 |
|
|
9812 | AZD 9567, AZD-9567, compound 15 [PMID: 29424542], example 1 [WO2016046260A1] | ||||
| azelaic acid |
|
|
|
7484 | Azelex®, Finacea®, ZK-62498 | |||
| AZ11657312 (salt free) |
|
7722 | ||||||
| B | Back to top | |||||||
| bafetinib |
|
|
7906 | INNO-406, Lyn-IN-1, NS-187 | ||||
| balamapimod |
|
9925 | MKI-833, MKI833 | |||||
| bardoxolone |
|
2717 | CDDO, RTA-401 | |||||
| baricitinib |
|
|
|
7792 | INCB-028050, INCB028050, LY-3009104, LY3009104, Olumiant® | |||
| BAYu9773 |
|
3381 | BAY u9773, BAY-u 9773 | |||||
| beclometasone |
|
|
7059 | beclomethasone, SCH-18020W | ||||
| beclometasone dipropionate |
|
|
5894 | beclomethasone dipropionate, Beconase®, Qnasl®, Vancenase® | ||||
| belnacasan |
|
9035 | VX-765 | |||||
| bentamapimod |
|
9926 | AS-602801, AS602801, PGL-5001, PGL5001 | |||||
| benzodrocortisone |
|
9731 | compound 1 [WO2013071010], hydrocortisone 17-benzoate | |||||
| 3beta-Hydroxy-20(29)-lupene |
|
9028 | Fagarasterol, Lupeol | |||||
| BGB-3111 |
|
9591 | ||||||
| BI-1935 |
|
9717 | BI 1935, example 3 [WO2007067836] | |||||
| BI-1950 |
|
9719 | ||||||
| BI-2545 |
|
|
9791 | BI2545, compound 19 [PMID: 29259743] | ||||
| BI605906 |
|
9357 | 3-Amino-4-(1,1-difluoro- propyl)-6-(4-methanesulfonyl- piperidin-1-yl)-thieno[2,3- b]pyridine-2-carboxylic acid amide, compound 115 [US20070293533] | |||||
| BI 653048 |
|
9715 | (R)-39, BI 653048 BS H3PO4, BI-653048, BI653048 | |||||
| BI 665915 |
|
9716 | BI-665915, compound 69 [PMID: 25671290] | |||||
| BI-6901 |
|
9714 | BI 6901, BI 6901, BI6901, eut-22 | |||||
| bimosiamose |
|
9049 | compound 15e [PMID: 9544210], TBC 1269, TBC-1269, TBC1269 | |||||
| BIRT 377 |
|
9720 | BIRT-377 | |||||
| BLZ945 |
|
8250 | BLZ 945, BLZ-945 | |||||
| BML-281 |
|
9664 | compound 3 [PMID: 18642892] | |||||
| BMS-1001 |
|
10191 | BMS1001, Example 1001 [WO2015160641A2] | |||||
| BMS-1166 |
|
9608 | compound 2c [PMID: 28613862], Example 1166 [WO2015160641A2] | |||||
| BMS-202 |
|
|
9607 | compound 1c [PMID: 28613862], PD1-PDL1 inhibitor 2 | ||||
| BMS-345541 |
|
5669 | BMS 345541, BMS345541 | |||||
| BMS-509744 |
|
9994 | BMS 509744, BMS509744, compound 3 [PMID:16682193] | |||||
| BMS-561392 |
|
6509 | BMS 561392, BMS561392, DPC-333 | |||||
| BMS-582949 |
|
|
7838 | BMS 582949, BMS582949, PS 540446, PS-540446, PS540446 | ||||
| BMS-681 |
|
|
9430 | compound 13d [PMID: 25893046] | ||||
| BMS-817399 |
|
|
9497 | compound 29 [PMID: 25101488] | ||||
| BMS-986142 |
|
|
9857 | BMS986142, compound 14f [PMID: 27583770] | ||||
| BMS-986195 |
|
9869 | BMS986195, Example 223 [US20160115126A1] | |||||
| BMS-986205 |
|
9707 | BMS986205 | |||||
| bosutinib |
|
|
|
5710 | Bosulif®, SK 606, SK-606, SKI 606 | |||
| brimonidine |
|
|
520 | Alphagan®, Lumify®, Mirvaso®, UK14,304, UK14304 | ||||
| BRL-15572 |
|
10 | BRL 15572, BRL-15,572, BRL15572 | |||||
| bromfenac |
|
|
|
7131 | AHR-10282B, Bromday®, Prolensa®, Xibrom® | |||
| BTK inhibitor 4b |
|
10094 | compound 4b [PMID: 30216722] | |||||
| BTP2 |
|
2438 | YM-58483 | |||||
| BX 471 |
|
767 | BX-471, BX-741 | |||||
| BX-795 |
|
|
8006 | BX 795, BX795 | ||||
| C | Back to top | |||||||
| C108297 |
|
9180 | Compound 52 [PMID:18226897] | |||||
| C391 |
|
9570 | compound 5 [PMID: 27994760] | |||||
| C646 |
|
7004 | ||||||
| CA-4948 |
|
10152 | AU-4948, AU4948, CA4948, example 1 [WO2015104688A1] | |||||
| canertinib |
|
5675 | CI 1033, CI-1033, PD 183805 dihydrochloride | |||||
| carprofen |
|
|
7141 | Ro-205720000 | ||||
| CBS-3595 |
|
9610 | ||||||
| CC-885 |
|
9224 | ||||||
| CCR2-RA-[R] |
|
|
9431 | analog 49 (Dasse et al., 2007) | ||||
| CCX354 |
|
10164 | CCX 354, CCX-354, CCX-354-C | |||||
| CDP840 |
|
9330 | CDP 840, CDP-840 | |||||
| celecoxib |
|
|
|
2892 | Celecox®, Onsenal®, SC-58635, SC58635 | |||
| cenerimod |
|
9824 | ACT-334441 | |||||
| cenicriviroc |
|
801 | TAK 652, TAK-652, TAK652, TBR-652 | |||||
| cerdulatinib |
|
8957 | PRT 062070, PRT-062070, PRT-2070, PRT062070 | |||||
| cetirizine |
|
|
1222 | Reactine®, Zyrtec® | ||||
| CG200745 |
|
10055 | CG-2, CG-200745, HDCG-0745 | |||||
| 2'3'-cGAMP |
|
|
9207 | cyclic [G(2',5')pA(3',5')p], cyclic GMP-AMP, Cyclic guanosine monophosphate-adenosine monophosphate | ||||
| CGI1746 |
|
|
8066 | CGI 1746, CGI-1746 | ||||
| CGI560 |
|
9264 | CGI-560 | |||||
| CH-4051 |
|
9844 | Formula (10) [WO2012078708A1] | |||||
| chloroquine |
|
|
|
5535 | Aralen®, chloraquine, Malaquin® | |||
| CHMFL-BTK-11 |
|
9516 | ||||||
| cicaprost |
|
1917 | ZK 96480, ZK-96480 | |||||
| ciclesonide |
|
|
7469 | Alvesco®, Omnaris®, RPR-251526 | ||||
| ciforadenant |
|
10190 | CPI-444, CPI444, V-81444, V81444 | |||||
| cilomilast |
|
|
7407 | SB-207499 | ||||
| cipemastat |
|
6466 | Ro 28-2653 | |||||
| clemastine |
|
|
6063 | HS-592, meclastin, Tavegil®, Tavist® | ||||
| clemizole |
|
10285 | ||||||
| clobenpropit |
|
1223 | VUF 9153, VUF-9153 | |||||
| clobetasone |
|
|
9088 | Eumovate® | ||||
| clodronic acid |
|
|
9605 | Bonefos®, Clasteon ®, clodronate, Loron® | ||||
| clofazimine |
|
|
9184 | Lamprene® | ||||
| clopidogrel (active metabolite) |
|
1772 | ||||||
| CM4620 |
|
10087 | CM-4620, compound I [WO2016138472A1] | |||||
| CNX-774 |
|
9266 | ||||||
| compound 48/80 |
|
5531 | ||||||
| compound 3a [Pipionne et al, 2018] |
|
9965 | ||||||
| compound 12a [PMID: 29031075] |
|
9684 | ||||||
| compound 19a [PMID: 26506089] |
|
9842 | ||||||
| compound 5b [PMID: 29457898] |
|
9835 | ||||||
| compound 18c [PMID: 25901531] |
|
9227 | ||||||
| compound 7c [PMID: 22041175] |
|
9931 | ||||||
| compound 8c [PMID: 28760529] |
|
9671 | ||||||
| Compound 9 [doi:10.26434/chemrxiv.7072592.v1] |
|
10083 | ||||||
| compound 17d [PMID: 23099093] |
|
8196 | ||||||
| compound 7d [PMID: 29672049] |
|
9937 | ||||||
| compound 5e [PMID: 28580438] |
|
9712 | ||||||
| compound 20f [PMID: 28520415] |
|
9961 | ||||||
| compound 7f [PMID: 29191554] |
|
|
9794 | example 32 [WO2011078413] | ||||
| compound 7f [PMID: 29283260] |
|
9780 | ||||||
| compound 2g [PMID: 27390066] |
|
9682 | ||||||
| compound 4g [PMID: 2680437] |
|
9198 | ||||||
| compound 8ic [PMID: 19081254] |
|
9478 | CCR4 Antagonist | |||||
| compound III [PMID: 24045148] |
|
9709 | ||||||
| compound II [PMID: 21329883] |
|
9579 | ||||||
| compound 17l [PMID: 26288691] |
|
10035 | ||||||
| compound 29 [Moslin et al., 2017] |
|
9992 | ||||||
| compound 12p [Larson et al., 2017] |
|
9690 | ||||||
| compound 11 [PMID: 29442501] |
|
9819 | ||||||
| compound 12 [PMID: 27448772] |
|
|
9453 | |||||
| compound 15 [PMID: 25411721] |
|
9078 | example 252 [WO2007110237] | |||||
| compound 15 [PMID: 29852070] |
|
9997 | ||||||
| compound 16 [PMID: 26794040] |
|
9223 | ||||||
| compound 17 [PMID: 29741897] |
|
10005 | ||||||
| compound 1 [PMID: 24930776] |
|
9092 | DB36 | |||||
| compound 1 [PMID: 28611375] |
|
9673 | ||||||
| compound 21 [PMID: 22802221] |
|
6918 | C21 | |||||
| compound 21 [PMID: 24900635] |
|
8187 | ||||||
| compound 24 [PMID: 26987013 ] |
|
9252 | ||||||
| compound 25 [PMID: 28038940] |
|
9700 | ||||||
| compound 27 [PMID: 24900635] |
|
10133 | ||||||
| compound 28 [PMID: 28671460] |
|
9670 | ||||||
| compound 36 [PMID: 21958547] |
|
9391 | ||||||
| compound 37 [PMID: 29193967] |
|
9797 | ||||||
| compound 3 [PMID: 28603634] |
|
9628 | ||||||
| compound 3 [PMID: 29633584] |
|
9960 | ||||||
| compound 41 [PMID: 25000588] |
|
9349 | ||||||
| compound 43 [PMID: 26751273] |
|
9492 | ||||||
| compound 47 [PMID: 28737909] |
|
9646 | ||||||
| compound 52 [PMID: 28541707] |
|
10001 | ||||||
| compound 76 [PMID: 28657314] |
|
9609 | ||||||
| compound 9 [PMID: 26006010] |
|
9761 | ||||||
| compound 3v [PMID: 27390066] |
|
9683 | ||||||
| compound 1 [WO2012007375] |
|
8084 | ||||||
| compound 7 [WO2012007375] |
|
8085 | ||||||
| CORM-2 |
|
9535 | ||||||
| CP-195543 |
|
6155 | CP 195543, CP-195,543, CP195543 | |||||
| CPUY192018 |
|
9710 | compound 18e [PMID: 26258437], compound 2 [PMID: 24512214] | |||||
| CR6086 |
|
9845 | ||||||
| CRAC channel inhibitor 5b [PMID: 26256403] |
|
10042 | ||||||
| CRAC channel inhibitor 1 [PMID: 26256403] |
|
10041 | ||||||
| crenolanib |
|
|
7882 | ARO-002, CP 868596, CP-868,596, CP-868596 | ||||
| crisaborole |
|
|
9151 | AN 2728, AN2728, compound 5b [PMID: 19303290], Eucrisa® | ||||
| cromoglicic acid |
|
|
7608 | cromoglycate, cromolyn, cromolyn sodium, FPL-670, Intal®, Opticrom®, sodium cromoglicate | ||||
| CRX-555 |
|
10091 | CRX555, N-[(3R)-3-(Octanoyloxy)myristoyl]-O-[2-[[(3R)-3-(octanoyloxy)myristoyl]amino]-3-O-[(3R)-3-(octanoyloxy)myristoyl]-4-O-phosphono-2-deoxy-beta-D-glucopyranosyl]-L-serine | |||||
| CU-CPT8m |
|
|
9795 | 7-(m-Tolyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide, compound 5 [PMID: 29155428] | ||||
| CX549 |
|
9701 | compound 63 [WO2016048861], CX-549 | |||||
| CXCR4 antagonist 22 |
|
10146 | ||||||
| CY-09 |
|
10057 | ||||||
| CZ415 |
|
9837 | compound 3 [PMID: 27563401], CZ-415 | |||||
| D | Back to top | |||||||
| D4476 |
|
5940 | casein kinase I inhibitor, CK1 inhibitor, D 4476 | |||||
| dagrocorat |
|
9650 | PF-00251802 | |||||
| danirixin |
|
8500 | GSK-1325756B, GSK1325756, GSK1325756B | |||||
| dapansutrile |
|
10056 | OLT-1177, OLT1177 | |||||
| darapladib |
|
|
6696 | SB 480848, SB-480848 | ||||
| dasatinib |
|
|
|
5678 | BMS 345825, BMS 354825, BMS 35482513, Sprycel® | |||
| DDR1/2 inhibitor 5n |
|
|
10105 | |||||
| decernotinib |
|
|
8309 | adelatinib, VRT-831509, VX-509 | ||||
| deflazacort |
|
|
9477 | Emflaza®, MDL 458 | ||||
| delgocitinib |
|
9619 | JTE-052, JTE052 | |||||
| desloratadine |
|
|
7157 | Clarinex®, SCH-34117 | ||||
| dexamethasone |
|
|
|
2768 | Decadron®, desametasone, fluormethylprednisolone | |||
| dezapelisib |
|
9728 | compound 67 [PMID: 22924688], example 15 [WO2011008487], INCB 40093, INCB40093 | |||||
| diamorphine |
|
9082 | acetomorphine, diacetylmorphine, heroin | |||||
| diclofenac |
|
|
|
2714 | Cataflam®, CGP-45840B, GP-45840, Voltaren®, Voltarol® | |||
| difamilast |
|
9776 | example 352 [WO2007058338], MM36, OPA-15406 | |||||
| diflapolin |
|
10080 | ||||||
| diflunisal |
|
|
|
7162 | Dolobid® | |||
| dilmapimod |
|
7815 | SB-681323 | |||||
| dimethyl fumarate |
|
|
7045 | BG-12, BG00012, fumaric acid, Tecfidera® | ||||
| dimethyl itaconate |
|
9939 | dimethylitaconate, itaconic acid dimethyl ester | |||||
| dimetindene |
|
|
10101 | (+/-)-dimethindene, dimethindene, dimethpyrindene, Fenistil®, Vibrocil® | ||||
| (S)-dimetindene |
|
10104 | (+)-dimethindene, (+)-dimetindene, (S)-dimethindene | |||||
| diminazene |
|
|
10307 | Azidin®, Berenil®, Pirocide® | ||||
| dinaciclib |
|
7379 | SCH727965 | |||||
| diphenylpyraline |
|
|
7165 | Hispril® | ||||
| diprovocim-1 |
|
10341 | compound 3 [PMID: 30272974] | |||||
| diroleuton |
|
|
9775 | 8,11,14-Eicosatrienoic acid, DGLA, dihomo-gamma-linolenic acid, DS107, Homo-gamma-linolenic acid | ||||
| DMAT |
|
|
9323 | 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole, CK2 Inhibitor II | ||||
| DO264 |
|
10250 | compound 46, DO-264 | |||||
| doramapimod |
|
|
5668 | BIRB 796BS, BIRB-796, BIRB796 | ||||
| doxycycline |
|
|
|
6464 | BMY-28689, Monodox®, Vibramycin® | |||
| dual sEH/FAAH inhibitor 11 |
|
10124 | compound B-11 [WO2017160861], example 28 [WO2017160861] | |||||
| duvelisib |
|
|
7795 | compound 4904 [Patent US8193182], Copiktra®, INK-1197, IPI-145 | ||||
| E | Back to top | |||||||
| 6E11 |
|
9749 | ||||||
| E6201 |
|
7836 | E 6201, E-6201 | |||||
| edicotinib |
|
8942 | JNJ-40346527, JNJ40346527, US8497376, 15 | |||||
| EG01377 |
|
|
9904 | (3-((5-(4-(aminomethyl)phenyl)-2,3-dihydrobenzofuran)-7-sulfonamido)thiophene- 2-carbonyl)-L-arginine, compound 1 [PMID: 29648813] | ||||
| elubirixin |
|
8499 | SB 656933, SB-656933, SB656933 | |||||
| enexasogaol |
|
9773 | 6-Shogaol, [6]-shogaol, trans-6-shogaol | |||||
| EP4A |
|
1952 | EP4A, L-161982, L161982 | |||||
| epacadostat |
|
8221 | IDO inhibitor 1, INCB 24360, INCB-24360, INCB024360 | |||||
| ER-27319 |
|
9611 | ||||||
| esflurbiprofen |
|
|
|
9420 | (S)-flurbiprofen, BTS-24332, SFPP, TT-063 | |||
| etodolac |
|
|
7185 | AY-24236, Lodine® | ||||
| etoricoxib |
|
|
|
2896 | Arcoxia®, MK 0663, MK-0663, MK0663 | |||
| etrasimod |
|
9331 | APD-334, APD334, APD334-003, compound 4 [PMID: 25516790] | |||||
| everolimus |
|
|
5889 | Afinitor®, Certican®, RAD-001, RAD001, rapamycin, 42-O-(2-hydroxyethyl)-, Zortress® | ||||
| evobrutinib |
|
9752 | A250 [WO2012170976], M-2951, M2951, MSC 2364447, MSC-2364447C, MSC2364447C | |||||
| example 131 [WO2009133348] |
|
8489 | ||||||
| example 25 [WO2018228934] |
|
10201 | ||||||
| example 36 [WO2016177845] |
|
9555 | ||||||
| F | Back to top | |||||||
| F16357 |
|
9255 | Compound 39 [PMID: 19791800], Example 1 in WO2007147824 | |||||
| F215 |
|
10121 | ||||||
| fenebrutinib |
|
|
9299 | Example 130 [US20140194408], GDC-0853, GDC0853, RG-7845, RG7845 | ||||
| fenoprofen |
|
|
4820 | fenoprofen calcium, Nalfon® | ||||
| fevipiprant |
|
|
8995 | NVP-QAW039, QAW039 | ||||
| fexofenadine |
|
|
4819 | Allegra®, fexofenadine HCl | ||||
| filgotinib |
|
|
7913 | GLPG-0634, GLPG0634 | ||||
| fimepinostat |
|
8952 | CUDC 907, CUDC-907, PI3K/HDAC Inhibitor centn | |||||
| fingolimod |
|
|
2407 | FTY-720, FTY720, Gilenya® | ||||
| FIPI |
|
8781 | compound 14 [PMID: 19136975] | |||||
| fludroxycortide |
|
|
7606 | Cordran®, flurandrenolide, flurandrenolone, Haelan® | ||||
| flufenamic acid |
|
|
|
2447 | ||||
| fluorescent MIF ligand B |
|
|
9987 | |||||
| flurbiprofen |
|
|
4194 | Ansaid®, Froben® | ||||
| fluticasone |
|
|
6699 | Advair®, Avamys®, Flovent HFA®, Veramyst® | ||||
| fluvoxamine |
|
|
|
7189 | Luvox®, U-23000 | |||
| formoterol |
|
|
3465 | BD-40A, CGP-25827A, Foradil®, Oxeze/Oxis®, YM-08316 | ||||
| fosdagrocorat |
|
9649 | PF-04171327 | |||||
| fostamatinib |
|
|
|
7796 | R 788, R-788, R7935788, Tavalisse® | |||
| FR122047 |
|
5191 | FR 122047, FR 122047 hydrochloride, FR-122047 | |||||
| G | Back to top | |||||||
| gabapentin |
|
|
|
5483 | CI 945, Go 3450, GOE 2450, GOE 3450, Neurontin® | |||
| Galapagos MAPKAPK5 inhibitor D |
|
9848 | compound 183 [WO2007138072A2] | |||||